Dr. Epstein is the Staff President of B & L Music and Ethics Societies.
Miran Epstein was born and educated in Tel Aviv, Israel. Since 2002, he lives and works in London, UK. Epstein received his MD in 1987 from the Sackler School of Medicine, Tel Aviv University. He received his MA and PhD in history and philosophy of science, both with distinction, in 1996 and 2004, respectively, from the Cohn Institute for the History and Philosophy of Science and Ideas, Tel Aviv University. Epstein is Reader in Medical Ethics at Bart and the London School of Medicine, Queen Mary University of London. He has published extensively on a wide spectrum of issues in medical ethics and is a Key Opinion Leader On Organ Transplantation (The Transplantation Society) and a UK Emissary on behalf of the Declaration of Istanbul on Organ Trafficking and Transplant Tourism Custodian Group.
Dr. Epstein leads and delivers the Ethics & Law module for MB BS, B Med Sci, and BSc/MA in Global Health at Barts and The London School of Medicine
Topics for PhD supervision:
Dr. Epstein welcomes proposals for postgraduate research in any area of medical ethics, especially such that involve historical aspects.
Sociology and history of medical ethics and bioethics; history, sociology and philosophy of science and medicine.
1. Epstein M. Rhetoric and ideology. bmj.com 14 November 2011. http://www.bmj.com/content/343/bmj.d7166?tab=responses.
2. Epstein M. The origins of organ transplantation: Surgery and laboratory science, 1880–1930. Book review. Medical History 2011; 55(4): 560-62.
3. Wilson M, Epstein M. The dark side of the sun. BMJ 2011; 343: 919.
4. Wilson M, Epstein M. The dark side of the sun. bmj.com 21 October 2011. http://www.bmj.com/content/343/bmj.d6593/reply#bmj_el_271832.
5. Al Ameri MN, Epstein M, Johnston A. Generic and therapeutic substitution: a response to our critic. International Journal of Clinical Pharmacy 2011; 33(6): 881.
6. Caplan AL, Danovitch G, Shapiro M, Lavee J, Epstein M. Time for a boycott of Chinese science and medicine pertaining to organ transplantation. Lancet 2011; 378: 1218.
7. Epstein M. Surprising revelations about the organ market. bmj.com 4 August 2011. http://www.bmj.com/content/343/bmj.d4867/reply#content-block.
8. Epstein M, Martin D, Danovitch G. Caution: deceased donor organ commercialism! Transplant International 2011; 24: 958-964.
9. Epstein M, Wilson M. Consent in emergency care research. Lancet 2011; 378(9785): 26.
10. Epstein M. Critique of moral judgment: sociology versus neuroscience. American Journal of Bioethics Neuroscience 2011; 2(2): 26-28.
11. Epstein M. The truth of scientific medicine. Book review. Sociology of Health and Illness 2011; 32 (7): 1120–1121.
12. Epstein M. If I were a rich man could I sell a pancreas? A study in the locus of oppression. Journal of Medical Ethics 2011; 37: 109-112.
13. Al Ameri M, Epstein M, Johnston A. Generic and therapeutic substitutions: are they always ethical in their own terms? Pharmacy World & Science 2010; 32(6): 691-5.
14. Epstein M. The Filipino connection: a response to our critics. bmj.com 6 September 2010. http://www.bmj.com/content/336/7657/1377.extract/reply#bmj_el_241272.
15. Epstein M, Chua A, Danovitch GM. The Filipino connection. bmj.com 15 August 2010. http://www.bmj.com/cgi/eletters?lookup=by_date&days=1#240338.
16. Epstein M. Capitalising on the disenfranchised. bmj.com 7 May 2010. http://www.bmj.com/cgi/eletters/340/may04_1/c2188#235422.
17. Epstein M. How will the economic downturn affect academic bioethics? Bioethics 2010; 24(5): 226–233.
18. Al Ameri M, Johnston A, Epstein M. Ethical issues in generic and therapeutic substitution. Pharmacy World & Science 2010; 32: 269.
19. Epstein M. The organ crisis. Project Syndicate 26 March 2010. http://www.project-syndicate.org/commentary/mepstein1/English.
20. Epstein M. The political economy of death and the history of its criteria. Reviews in the Neurosciences 2009; 20(3-4): 293-297.
21. Epstein M. Pros and cons of a regulated market in organs. Lancet 2009; 374(9707): 2049-50.
22. Epstein M. Death with dignity: Thin ice over murky water. bmj.com 28/7/09. http://www.bmj.com/cgi/eletters/339/jul16_1/b2883#217825.
23. Epstein M. Sociological and ethical issues in transplant commercialism. Current Opinion in Organ Transplantation 2009; 14(2): 134-139.
24. Epstein M, Danovitch GM. Is altruistic directed living unrelated organ donation a legal fiction? Nephrology, Dialysis & Transplantation 2009; 24: 357-360.
25. Epstein M. ‘Tell us what you want to do, and we’ll tell you how to do it ethically’. Academic bioethics: routinely ideological and occasionally corrupt. American Journal of Bioethics 2008; 8(8): 63-65.
26. Epstein M. The Declaration of Istanbul on Organ Trafficking and Transplant Tourism: an important international achievement with one disturbing loophole. bmj.com 4/7/2008. http://www.bmj.com/cgi/eletters?lookup=by_date&days=2#198338.
27. Zosmer A, Epstein M, Al-Shawaf T. Ethical recruitment of patients for PGS trial. Human Reproduction 2008; 23(6): 1472.
28. Epstein M. The Ethics of regulated markets in organs: juggling with interests and shame. Proceedings of 3eme Colloque France-Maghreb, Tunis 2007; 47-51.
29. Epstein M. The ethics of poverty and the poverty of ethics: the case of Palestinian prisoners in Israel seeking to sell their kidneys in order to feed their children. Journal of Medical Ethics 2007; 33: 473-474.
30. Epstein M. Clinical trials in the developing world. Lancet 2007; 369(9576): 1859.
31. Epstein M. Legal and institutional fictions in medical ethics: a common, and yet largely overlooked, phenomenon. Journal of Medical Ethics 2007; 33(6): 362-364.
32. Epstein M. The concept of brain death: let us not ignore the context of its social reception. jme.com 17/4/2007. http://jme.bmj.com/cgi/eletters/33/4/197.
33. Epstein M. Legitimizing the shameful: end-of-life ethics and the political economy of death. Bioethics 2007; 21(1): 23-31.
34. Epstein M, Wingate DL. Is the NHS research ethics committees system to be outsourced to a low-cost off-shore call centre? Reflections on human research ethics after the Warner Report. Journal of Medical Ethics 2006; 33(1): 45-47.
35. Epstein M. Why effective consent presupposes autonomous authorization: a counter-orthodox argument. Journal of Medical Ethics 2006; 32: 342-345.
36. Epstein M. An age-old dilemma. Ha’aretz.com 5 April 2002. http://www.haaretz.com/culture/books/an-age-old-dilemma-1.48607.
37. Epstein M. The right to die with dignity in Israel: other thoughts about ethics and policy. Journal of Medicine & Law, Nov 2001; 240-255 (Hebrew).
38. Epstein M. The new medical ethics and the ideology of the health care market: the birth of a new social consciousness. Zmanim Quarterly for History TAU, 2001; 73: 88-95 (Hebrew).
39. Epstein M. Health, market, and alleged liberty: the Patient’s Rights Act in historical context. Journal of Medicine & Law April 2000; 6-13 (Hebrew).
40. Epstein M. Euthanasia in historical context: autonomy and rationing. Harefuah August 1999; 137(3-4): 117-119 (Hebrew).
41. Mozes B., Epstein M. et al. Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion 1989; 29(6): 473-476.
Books and chapters:
1. Epstein M. A market in organs. In M. Veroux (ed.) Kidney transplantation: Challenging the future. Bentham Science Publishers, Netherlands (in press for 2012).
2. Hakim N, Papalois V, Epstein M (eds.) Modern Surgery: Ethical and Legal Issues. London: Imperial College Press (in press for 2012). http://www.worldscibooks.com/medsci/p578.html
3. Epstein M. Ethical issues in transplantation. In N. Hakim (ed.) Introduction to Transplantation. London: Imperial College Press, 2012; pp. ***.
4. Epstein M. Introduction to the philosophy of science. In C. Seale (ed.) Researching Society and Culture, Third Edition. London: Sage, 2012; pp. 7-28.
5. Epstein M. Pseudononcommercialism: the Trojan horse of the organ market. In W. Weimar, M. Bos and J. van Busschbach (eds.) Organ transplantation: ethical, legal and psychological aspects. Expanding the European platform. Emmerich: Pabst Science Publishers, 2011; pp. 135-141.
6. Epstein M. Air Pollution and Public Health in Israel: Current State, Social Aspects, and the Change Needed. Heschel Center, Jerusalem Institute for Israel Studies. 2001; 82 pp. (Hebrew).
7. Epstein M. Air pollution and public health in Israel. In D. Khenin (ed.) Vital Signs 2001. Worldwatch Institute, Heschel Center and the Jerusalem Institute for Israel Studies.
8. Epstein M. Air pollution and public health in Israel. In D. Khenin (ed.) Vital Signs 2000. Worldwatch Institute, Heschel Center and the Jerusalem Institute for Israel Studies (Hebrew).
View all Miran Epstein's Research Publications at: http://www.researchpublications.qmul.ac.uk